NEW DELHI: Indian multinational pharmaceutical companies Dr Reddy's Laboratories Ltd and Cipla Limited on Wednesday said they have entered into a partnership agreement with ABCD Technologies LLP, which is to be renamed as IndoHealth Services LLP.

The two conglomerates are contributing up to Rs 40 crore each corresponding to the contribution by the other partners in the target entity which is a newly incorporated limited liability partnership (LLP) and has not commenced any business activities.

The proposed business of the target entity will be carried out with an objective to facilitate the digitisation of the healthcare infrastructure in India towards enhancement of good distribution practices in support of the National Digital Health Mission of the government, they added.

While Cipla said the nature of consideration is cash infusion as capital contribution towards partnership, Dr. Reddy's said the nature of consideration is cash infusion as capital contribution and/or loan. Contribution of up to Rs 40 crore is for up to 20 percent share of profit-loss in the target entity, the companies said.

India inc mop up record Rs 1,88,900-Cr in equity capital this fiscal

UN Report: India's 2021 economic output may remain below 2019 level

IMF's big statement on Indian economy, regarding recovery